GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Accumulated other comprehensive income (loss)

Aprinoia Therapeutics (Aprinoia Therapeutics) Accumulated other comprehensive income (loss) : $-1.33 Mil (As of Jun. 2023)


View and export this data going back to 2050. Start your Free Trial

What is Aprinoia Therapeutics Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Aprinoia Therapeutics's Accumulated other comprehensive income (loss) for the quarter that ended in Jun. 2023 was $-1.33 Mil.

Aprinoia Therapeutics's quarterly Accumulated other comprehensive income (loss) declined from Jun. 2022 ($0.00 Mil) to Dec. 2022 ($-0.97 Mil) and declined from Dec. 2022 ($-0.97 Mil) to Jun. 2023 ($-1.33 Mil).

Aprinoia Therapeutics's annual Accumulated other comprehensive income (loss) increased from . 20 ($0.00 Mil) to Dec. 2021 ($-0.49 Mil) but then declined from Dec. 2021 ($-0.49 Mil) to Dec. 2022 ($-0.97 Mil).


Aprinoia Therapeutics Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Aprinoia Therapeutics's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aprinoia Therapeutics Accumulated other comprehensive income (loss) Chart

Aprinoia Therapeutics Annual Data
Trend Dec21 Dec22
Accumulated other comprehensive income (loss)
-0.49 -0.97

Aprinoia Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23
Accumulated other comprehensive income (loss) -0.49 - -0.97 -1.33

Aprinoia Therapeutics Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.


Aprinoia Therapeutics Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Aprinoia Therapeutics's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.


Aprinoia Therapeutics (Aprinoia Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aprinoia Therapeutics Inc (NAS:APRI) » Definitions » Accumulated other comprehensive income (loss)
Comparable Companies
Traded in Other Exchanges
N/A
Address
Website
Aprinoia Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in protecting patients' brain health and changing clinical outcomes for a broad range of neurodegenerative diseases by developing novel, highly sensitive and selective diagnostic tools and novel therapeutics. Neurodegenerative diseases are relentless and largely fatal, resulting from progressive loss of nerve cells in the brain and, depending on the specific disorders, can affect a broad range of cognitive, behavioral, and motor functions, such as memory, thinking, speaking, walking, and breathing. It is developing several different diagnostic and therapeutic platforms such as abnormal protein aggregates of tau and alpha synuclein ("?-Syn") that are toxic to brain cells.

Aprinoia Therapeutics (Aprinoia Therapeutics) Headlines

No Headlines